Organization Profile

You just read:

Phase 3 ASCEND Study of Pirfenidone in Idiopathic Pulmonary Fibrosis Presented at American Thoracic Society (ATS) and Published in New England Journal of Medicine

News provided by

InterMune, Inc.

May 18, 2014, 17:04 ET